MHRA consults patients about ADR reporting
Left to right: Lord Warner with the three directors of Ask About
Medicines Week Joanne Shaw, Melinda Letts and David Dickinson |
The Medicines and Healthcare products
Regulatory Agency has written to hundreds of patients inviting them to take part in a survey about the reporting of adverse drug reactions.
Speaking at the launch of Ask
About Medicines Week in London, health
minister Lord Warner, said: “The MHRA will begin a pre-pilot survey
of patients who have experienced suspected adverse drug reactions
during the year. The results of the survey will help to shape the future
design of direct
patient reporting systems. We want this to
be a scheme that listens to patients and takes their experiences of adverse
drug reactions seriously.”
Lord Warner welcomed the various initiatives that are part of AAMW and
said he supported the key message of informed choice. He added that the
Government wants to empower patients to manage their own care. “We
are looking actively to improve availability of medicines OTC not just
for acute, short term, self-limiting conditions, but also for long-term
conditions,” he said. |
The
Pharmaceutical Journal
Acrobat
Reader